|
MechanismNK1R antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date01 Sep 2015 |
100 Clinical Results associated with Tesaro Bio Netherlands BV
0 Patents (Medical) associated with Tesaro Bio Netherlands BV
100 Deals associated with Tesaro Bio Netherlands BV
100 Translational Medicine associated with Tesaro Bio Netherlands BV